-
Join us in CPHI Milan-
September 04, 2024 -
Sinopep
Join us in CPHI Milan
View More -
-
Join us in CPHI US & TIDES US-
April 28, 2024
-
Sinopep
Join us in CPHI US & TIDES US
View More -
-
Keeping up with the trend and showing international perspective - Sinopep in DCAT Week 2024 in New York, USA-
March 27, 2024
-
Sinopep
From March 18th to 21st, 2024, the DCAT Week, the annual meeting of the United States Association for Drug and Chemical Transactions, was successfully convened in New York, USA.
View More -
-
Welcome to 2024 DCAT Week-
March 08, 2024
-
Sinopep
Welcome to 2024 DCAT Week
View More -
-
Sinopep has obtained FDA First Adequate Letter for Semaglutide-
December 18, 2023
-
Sinopep
Sinopep received the First Adequate Letter from US FDA on Dec. 10, 2023 for the Semaglutide DMF (No. 036273) following FDA’s full scientific review.
View More -
-
Sinopep has obtained FDA First Adequate Letter for Liraglutide-
October 13, 2023
-
Sinopep
Sinopep received the First Adequate Letter from US FDA on Oct 5, 2023 for the Liraglutide DMF (No. 034104) following FDA’s full scientific review.
View More -
-
Welcome to 2023 DCAT Week-
March 20, 2023
-
Sinopep
Sinopep-Allsino Biopharmaceutical Co., Ltd will participate in the 2023 DCAT Week (Annual Meeting of the Association for the Joint Trade of Pharmaceuticals and Chemicals) in New York, USA on March 20-23 (local time). We sincerely invite all industry exper
View More -
